Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fendo.2026.1968836.s002In women aged 35 years or younger with diminished ovarian reserve (DOR), we evaluated whether two pretreatment markers, anti-Müllerian hormone (AMH) and antral follicle count (AFC), can stratify the risk of poor ovarian response (POR) before stimulation. This retrospective cohort included IVF/ICSI cycles from four centres in Zhejiang, China (2022–2025). Of 1,754 DOR-eligible cycles, 157 were removed in two post-hoc phenotype-cleaning exclusions (PCOS, n = 139; AMH ≥5 ng/mL without PCOS, n = 18), leaving 1,597 cycles. POR was defined as ≤3 oocytes. Cycles were cross-classified by AFC ≤5 and AMH
Keyword(s):
anti-Müllerian hormone; antral follicle count; Cell Metabolism; diminished ovarian reserve; nomogram.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)